Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized trial of celecoxib, midazolam, or no intervention for postoperative delirium feasibility
ACTRN12625001042437Phase 3Not yet recruiting
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Oct 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of celecoxib and midazolam in delirium (3 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoints: Screen failure rate, Recruitment rate and 1 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
celecoxibmidazolam
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12625001042437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001042437.